12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

VBL Therapeutics preclinical data

In mouse models of IBD, VB-201 alleviated wasting disease and restrained gastrointestinal inflammation vs. controls. Data were presented at the Digestive Disease Week...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >